Polar Securities Inc increased Transalta Corp (TAC) stake by 706.09% reported in 2016Q4 SEC filing. Polar Securities Inc acquired 2.47M shares as Transalta Corp (TAC)’s stock rose 24.72%. The Polar Securities Inc holds 2.82 million shares with $15.52 million value, up from 350,000 last quarter. Transalta Corp now has $1.49 billion valuation. The stock increased 0.98% or $0.05 on May 3, reaching $5.15. About 35,101 shares traded. TransAlta Corporation (USA) (NYSE:TAC) has risen 12.83% since September 26, 2016 and is uptrending. It has outperformed by 1.41% the S&P500.
Adage Capital Partners Gp Llc decreased Five Prime Therapeutics Inc (FPRX) stake by 10.59% reported in 2016Q4 SEC filing. Adage Capital Partners Gp Llc sold 225,100 shares as Five Prime Therapeutics Inc (FPRX)’s stock declined 3.54%. The Adage Capital Partners Gp Llc holds 1.90 million shares with $95.21 million value, down from 2.13 million last quarter. Five Prime Therapeutics Inc now has $880.22 million valuation. The stock decreased 1.98% or $0.64 during the last trading session, reaching $31.65. About 328,024 shares traded. Five Prime Therapeutics Inc (NASDAQ:FPRX) has declined 39.20% since September 26, 2016 and is downtrending. It has underperformed by 50.62% the S&P500.
Adage Capital Partners Gp Llc increased Dr Pepper Snapple Group Inc (NYSE:DPS) stake by 36,400 shares to 505,186 valued at $45.81M in 2016Q4. It also upped Intuit (NASDAQ:INTU) stake by 190,200 shares and now owns 350,400 shares. Post Hldgs Inc (NYSE:POST) was raised too.
Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.41, from 1.15 in 2016Q3. It dropped, as 19 investors sold FPRX shares while 69 reduced holdings. 16 funds opened positions while 49 raised stakes. 24.63 million shares or 4.67% less from 25.83 million shares in 2016Q3 were reported. Blackrock Invest Mngmt Limited has invested 0.01% of its portfolio in Five Prime Therapeutics Inc (NASDAQ:FPRX). Teachers Retirement Of The State Of Kentucky invested in 23,952 shares. Doheny Asset Mgmt Ca holds 6,150 shares. Tower Rech Capital Ltd Liability Corp (Trc) holds 0.01% or 1,123 shares in its portfolio. Gargoyle Inv Advisor Limited Liability Co reported 6,625 shares. California-based Eam Investors Ltd has invested 0.07% in Five Prime Therapeutics Inc (NASDAQ:FPRX). Da Davidson reported 0% in Five Prime Therapeutics Inc (NASDAQ:FPRX). Clarivest Asset Management Lc has 0.04% invested in Five Prime Therapeutics Inc (NASDAQ:FPRX) for 29,698 shares. Interest Gru Inc Inc stated it has 15,514 shares. First Tru Advisors LP owns 41,605 shares or 0.01% of their US portfolio. Credit Suisse Ag invested in 76,053 shares or 0% of the stock. Trillium Asset Ltd Liability Company reported 64,615 shares. Principal Group Inc accumulated 15,599 shares. Aqr Management Ltd Liability Com reported 128,095 shares. 107,934 are owned by Morgan Stanley.
Among 7 analysts covering Five Prime Therapeutics (NASDAQ:FPRX), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Five Prime Therapeutics had 11 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Friday, December 4 by Wells Fargo. Citigroup initiated it with “Buy” rating and $33 target in Friday, July 31 report. Zacks upgraded Five Prime Therapeutics Inc (NASDAQ:FPRX) on Tuesday, August 11 to “Sell” rating. As per Friday, March 11, the company rating was maintained by Credit Suisse. On Thursday, January 21 the stock rating was initiated by Credit Suisse with “Outperform”. BMO Capital Markets initiated it with “Market Perform” rating and $50 target in Tuesday, April 12 report. The stock has “Buy” rating by Citigroup on Tuesday, October 25. The stock of Five Prime Therapeutics Inc (NASDAQ:FPRX) earned “Sell” rating by Zacks on Friday, August 21. The firm earned “Outperform” rating on Monday, October 19 by Oppenheimer.
Since November 9, 2016, it had 0 buys, and 8 sales for $4.41 million activity. Williams Lewis T sold $1.51 million worth of stock or 30,000 shares. Another trade for 3,636 shares valued at $172,310 was sold by Sarena Francis Willard. Shares for $28,860 were sold by RINGO WILLIAM R. Another trade for 8,130 shares valued at $449,589 was made by Jensen Peder on Wednesday, November 9.
Analysts await Five Prime Therapeutics Inc (NASDAQ:FPRX) to report earnings on May, 4 after the close. They expect $-1.01 earnings per share, down 106.12% or $0.52 from last year’s $-0.49 per share. After $-0.73 actual earnings per share reported by Five Prime Therapeutics Inc for the previous quarter, Wall Street now forecasts 38.36% negative EPS growth.
Polar Securities Inc decreased Vca Inc (NASDAQ:WOOF) stake by 33,500 shares to 225,096 valued at $15.45M in 2016Q4. It also reduced St Jude Med Inc (NYSE:STJ) stake by 20,000 shares and now owns 30,000 shares. Privatebancorp Inc (NASDAQ:PVTB) was reduced too.
Among 5 analysts covering TransAlta (NYSE:TAC), 0 have Buy rating, 1 Sell and 4 Hold. Therefore 0 are positive. TransAlta had 11 analyst reports since August 24, 2015 according to SRatingsIntel. On Wednesday, May 4 the stock rating was downgraded by RBC Capital Markets to “Underperform”. The stock of TransAlta Corporation (USA) (NYSE:TAC) has “Sector Underperform” rating given on Tuesday, August 25 by IBC. The company was upgraded on Monday, August 24 by BMO Capital Markets. The firm earned “Sector Perform” rating on Monday, November 23 by RBC Capital Markets. The firm has “Sector Perform” rating by RBC Capital Markets given on Monday, November 7. The rating was maintained by RBC Capital Markets on Monday, November 2 with “Underperform”. Credit Suisse upgraded TransAlta Corporation (USA) (NYSE:TAC) on Wednesday, September 16 to “Neutral” rating. The stock of TransAlta Corporation (USA) (NYSE:TAC) earned “Sector Perform” rating by RBC Capital Markets on Friday, February 19. The firm earned “Market Perform” rating on Monday, January 18 by BMO Capital Markets. BMO Capital Markets downgraded it to “Market Perform” rating and $5 target in Thursday, January 14 report.